Taylor P M, Alexander R
Lepr India. 1976 Oct;48(4 Suppl):709-12.
Dapsone resistant patients treated with clofazimine 100 mg daily show a consistent response to treatment. Concern is expressed regarding the prolonged persistence of viable organisms during treatment, with the attendant risk of further resistance developing. The importance of prevention of this problem is discussed.
接受每日100毫克氯法齐明治疗的耐氨苯砜患者对治疗有持续反应。有人对治疗期间存活生物体的长期持续存在表示担忧，随之而来的是产生进一步耐药性的风险。讨论了预防此问题的重要性。
